We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+71.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$455M
AUM Growth
+$82.4M
Cap. Flow
+$53.4M
Cap. Flow %
11.72%
Top 10 Hldgs %
38.61%
Holding
1,671
New
529
Increased
423
Reduced
135
Closed
403

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$38M
2
MSFT icon
Microsoft
MSFT
+$27.5M
3
LLY icon
Eli Lilly
LLY
+$12.9M
4
META icon
Meta Platforms (Facebook)
META
+$6.48M
5
DHR icon
Danaher
DHR
+$5.85M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$68.6M
2
AVGO icon
Broadcom
AVGO
+$17.9M
3
NU icon
Nu Holdings
NU
+$15.9M
4
DECK icon
Deckers Outdoor
DECK
+$7.58M
5
SMCI icon
Super Micro Computer
SMCI
+$6.23M

Sector Composition

Rank Sector Weight
1 Technology 21.89%
2 Healthcare 13.56%
3 Industrials 12.93%
4 Communication Services 11.23%
5 Financials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLTH icon
1201
Duluth Holdings
DLTH
$162M
$9.02K ﹤0.01%
2,400
CRWD icon
1202
CrowdStrike
CRWD
$183B
$8.97K ﹤0.01%
128
-5,472
-98% -$389K
THR
1203
DELISTED
Thermon Group Holdings
THR
$8.95K ﹤0.01%
+300
New +$9.05K
ALLK
1204
DELISTED
Allakos
ALLK
$8.88K ﹤0.01%
13,600
ATOM icon
1205
Atomera
ATOM
$203M
$8.68K ﹤0.01%
3,300
OM icon
1206
Outset Medical
OM
$80.1M
$8.53K ﹤0.01%
840
WHWK
1207
Whitehawk Therapeutics
WHWK
$183M
$8.45K ﹤0.01%
4,100
FOSL icon
1208
Fossil Group
FOSL
$249M
$8.42K ﹤0.01%
7,200
CASS icon
1209
Cass Information Systems
CASS
$705M
$8.3K ﹤0.01%
+200
New +$8.28K
SGU icon
1210
Star Group
SGU
$415M
$8.22K ﹤0.01%
700
CRNC icon
1211
Cerence
CRNC
$375M
$8.19K ﹤0.01%
2,600
HCAT icon
1212
Health Catalyst
HCAT
$159M
$8.14K ﹤0.01%
+1,000
New +$7.23K
NSSC icon
1213
Napco Security Technologies
NSSC
$1.3B
$8.09K ﹤0.01%
+200
New +$9.8K
ESQ icon
1214
Esquire Financial Holdings
ESQ
$1.04B
$8.09K ﹤0.01%
+124
New +$7.16K
EGY icon
1215
Vaalco Energy
EGY
$552M
$8.04K ﹤0.01%
+1,400
New +$8.82K
IMA
1216
ImageneBio Inc
IMA
$63.2M
$7.79K ﹤0.01%
375
PFIS icon
1217
Peoples Financial Services
PFIS
$703M
$7.69K ﹤0.01%
+164
New +$7.54K
OMGA
1218
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$7.44K ﹤0.01%
6,100
JILL icon
1219
J. Jill
JILL
$261M
$7.4K ﹤0.01%
+300
New +$9.76K
WW
1220
DELISTED
WW International
WW
$7.37K ﹤0.01%
8,400
SGMT icon
1221
Sagimet Biosciences
SGMT
$460M
$7.2K ﹤0.01%
2,600
-3,200
-55% -$9.86K
METC icon
1222
Ramaco Resources Class A
METC
$664M
$7.02K ﹤0.01%
+620
New +$7.39K
ZVIA icon
1223
Zevia
ZVIA
$113M
$6.91K ﹤0.01%
6,400
VOR icon
1224
Vor Biopharma
VOR
$1.05B
$6.86K ﹤0.01%
490
CUE icon
1225
Cue Biopharma
CUE
$137M
$6.81K ﹤0.01%
300

Similar funds

Catalyst Funds Management's Q3 2024 Portfolio in Review

As of Q3 2024, Catalyst Funds Management held 1,671 positions worth $455M, up 22% from $373M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Catalyst Funds Management deployed $53.4M of net new capital in Q3 2024, opening 529 new positions and adding to 423 existing holdings. Its largest new stake was Microsoft: 64,400 shares worth $27.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $17.9M trimmed.

  • Catalyst Funds Management's largest Q3 2024 buy was Microsoft: 64,400 shares worth $27.7M.
  • Catalyst Funds Management added most to NVIDIA in Q3 2024, an estimated $38M increase.
  • Catalyst Funds Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $17.9M.
  • Catalyst Funds Management fully exited Apple in Q3 2024, selling an estimated $68.6M.
  • Catalyst Funds Management's ten largest holdings make up 39% of its $455M portfolio in Q3 2024.
  • Catalyst Funds Management opened 529 new positions and closed 403 in Q3 2024.
  • Catalyst Funds Management's portfolio value rose 22% quarter-over-quarter to $455M.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.